RewordedRisk Factors
Competition is based on several key criteria, including product price, product performance, product quality, product availability and security of supply, breadth of product offerings, geographic reach, responsiveness of product development in cooperation with customers, technical expertise expertise, timeliness of delivery, and customer service.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our Water Treatment Group and our agricultural product sales within our Industrial Food and Health Sciences Group are subject to seasonality and weather conditions, which could adversely affect our results of operations.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our agricultural product sales within our Industrial Food and Health Sciences Group are also seasonal, primarily corresponding with the planting season.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
Our access to third-party transportation is not guaranteed, and we may be unable to transport our products in a timely manner, or at all, in certain circumstances, or at economically attractive rates.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
AddedMD&A
We derive substantially all of our revenues from the sale of water treatment, specialty ingredients, and chemistry products to our customers in a wide variety of industries. We believe that we create value for our customers through superb service and support, quality products, personalized applications and trustworthy, creative employees
Read it in 10-K May 13, 2026 at sec.govopen_in_new
AddedMD&A
We completed the following acquisitions in fiscal 2026. The results of operations since the date of each acquisition and the assets, including goodwill associated with these acquisitions, are included in our Water Treatment segment with the exception of the MakWood lactate business, which is included in our Food & Health Sciences segment. Certain acquisitions discussed below are not included in Note 2 to our Consolidated Financial Statements as they were not deemed to be material enough to warrant disclosure.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
AddedMD&A
•On December 3, 2025, we acquired substantially all the assets and assumed certain liabilities of Redbird Chemical, Inc. (“Redbird”) for $4.6 million. Redbird distributed chemicals to its customers in eastern Texas within both the water treatment and industrial markets.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
AddedMD&A
•On July 2, 2025, we acquired the lactate business of MakWood, Inc. for $1.9 million. We had previously been party to a Distribution Agreement with MakWood for certain lactate products under the Mak Lak trade name. This acquisition agreement terminated the Distribution Agreement, and resulted in our acquisition of the lactate distribution business, including the customer list and associated brand name.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
AddedMD&A
•On July 1, 2025, we acquired substantially all the assets and assumed certain liabilities of PhillTech, LLC ("PhillTech") for $5.0 million. Located in Courtland, AL, PhillTech manufactured and distributed coagulants and corrosion control products for its water treatment customers.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
AddedMD&A
•On June 13, 2025, we acquired substantially all the assets and assumed certain liabilities of Hendrickson Enterprises, LLC and Polymer Technologies, LLC (collectively, "Hendrickson") for approximately $1.5 million. Hendrickson distributed water treatment chemicals and equipment to its customers via direct shipments from suppliers.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
AddedMD&A
•On April 25, 2025, we acquired substantially all of the assets and assumed certain liabilities of WaterSurplus, Inc. ("WaterSurplus") and related entities for approximately $149.9 million paid at closing, with an additional amount payable as an earnout of up to $53.7 million based on cumulative gross profit for the first five years. WaterSurplus is located in Rockford, IL and delivers sustainable water treatment solutions to customers throughout the United States.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
AddedMD&A
Effective beginning with the first quarter of fiscal 2026, we realigned our reporting segments to better reflect how we manage our operations and allocate resources. We believe this realignment better reflects the value our company provides to our customers and our evolution from a bulk commodity distributor into a specialty ingredients company. We now organize and manage our business by the following three segments, each of which meets the definition of reportable segments under ASC 280-10, Segment Reporting: Water Treatment, Food and Health Sciences, and Industrial Solutions. These segments are defined primarily by product and type of customer. Information presented in this annual report has been recast to align with the new segments. Additional information regarding these new segments is set forth in Note 15 to our Consolidated Financial Statements.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RemovedMD&A
We derive substantially all of our revenues from the sale of specialty chemicals and ingredients that we formulate, manufacture, blend and distribute, for our Water Treatment, Industrial, and Health and Nutrition customers.
Read it in 10-K May 14, 2025 at sec.govopen_in_new
RemovedMD&A
On January 31, 2025, we acquired substantially all the assets of Amerochem Corporation ("Amerochem") under the terms of a purchase agreement with Amerochem and its shareholders. Amerochem distributed water treatment chemicals and equipment to its customers primarily throughout North Carolina. The results of operations since the acquisition date and the assets are included in our Water Treatment segment.
Read it in 10-K May 14, 2025 at sec.govopen_in_new
RemovedMD&A
After the end of the fiscal year, on April 25, 2025, we acquired substantially all of the assets of Surplus Management, Inc. dba WaterSurplus ("WaterSurplus") for approximately $150 million, and may be obligated to pay up to an additional $53.7 million based on achieving certain earnings targets five years after the closing of the acquisition. WaterSurplus delivers sustainable water treatment solutions throughout the United States focused on membrane separation systems, engineering and design services, media filtration systems, new equipment and rental unit manufacturing and sales, along with rapid-response PFAS removal solutions for “forever chemicals”. WaterSurplus serves municipal water customers as well as customers in the food and beverage industry, offering patented products within its filtration business that reduce the frequency of membrane cleaning resulting in lower energy costs, downtime, and lower overall operational costs.
Read it in 10-K May 14, 2025 at sec.govopen_in_new
RewordedMD&A
The decrease increase in cash provided by operating activities in fiscal 2025 2026 as compared to fiscal 2024 2025 was primarily driven by increases favorable year-over-year changes in customer inventories and trade receivables as compared to the same period a result of higher sales, as well as higher inventory levels, partially offset by an increase in net income. year ago.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedMD&A
Gross profit for our Food and Health and Nutrition Sciences segment increased $3.7 decreased $4.6 million, or 13%, 6%, to $31.3 $67.3 million, or 21% of sales, for fiscal 2026, from $71.9 million, or 22% of sales, for fiscal 2025, from $27.6 million, or 19% of sales, for fiscal 2024. 2025.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedMD&A
Gross profit increased $31.9 $19.5 million, or 16%, 9%, to $245.1 million, or 23% of sales, for fiscal 2026, from $225.5 million, or 23% of sales, for fiscal 2025, from $193.6 million, or 21% of sales, for fiscal 2024. 2025.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedMD&A
SG&A expenses increased $16.8 $17.4 million, or 19% 16% to $123.8 million, or 11% of sales, for fiscal 2026, from $106.4 million, or 11% of sales, for fiscal 2025, from $89.6 million, or 10% of sales, for fiscal 2024. 2025.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedMD&A
Cash used in provided by financing activities included net debt borrowings of $95.0 million in fiscal 2026 and net debt borrowings of $50.0 million in fiscal 2025 and net debt repayments of $13.0 million in fiscal 2024. 2025.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedMD&A
The year-over-year increase was driven by sales growth in our Water Treatment segment, and Industrial Solutions segments, which grew 22% and 7%, respectively , while sales in our Industrial Food and Health and Nutrition segments Sciences segment declined year over year. slightly.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedMD&A
Water Treatment segment sales increased $83.2 $96.8 million, or 23%, 22%, to $543.3 million for fiscal 2026, as compared to $446.5 million for fiscal 2025, as compared to $363.3 million for fiscal 2024. 2025.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedMD&A
The For each acquisition, we allocate the fair value of the consideration we pay for each new acquisition is allocated transferred to the tangible assets and acquired, identifiable intangible assets assets, and liabilities assumed.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedMD&A
Gross profit for the Water Treatment Industrial Solutions segment increased $23.1 $1.0 million, or 23%, 3%, to $121.6 $32.8 million, or 27% 15% of sales, for fiscal 2025, 2026, from $98.5 $31.8 million, or 27% 15% of sales, for fiscal 2024. 2025.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedMD&A
Cash used in provided by financing activities was $78.6 million in fiscal 2026 compared to $14.8 million in fiscal 2025 compared to $37.4 million in fiscal 2024. 2025.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedMD&A
Gross profit for our Health and Nutrition the Industrial Solutions segment increased $3.7 $5.1 million, or 13%, 19%, to $31.3 $31.8 million, or 22% 15% of sales, for fiscal 2025, from $27.6 $26.7 million, or 19% 12% of sales, for fiscal 2024.
Read it in 10-K May 13, 2026 at sec.govopen_in_new
RewordedMD&A
The Credit Agreement contains customary events of default, default including failure to make payments under the Revolving Loan Facility, failure to comply with covenants in the Credit Agreement and other loan documents, cross default to other material indebtedness, our failure by us to pay or discharge material judgments, bankruptcy, and change of control. control of the Company.
Read it in 10-K May 13, 2026 at sec.govopen_in_new